Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study | Zendy

Anouk J. W. Gulpen | Zendy; Dionne C.W. Braeken | Zendy; Simon Schalla | Zendy; Hugo Ten Cate | Zendy; Harry J. Crijns | Zendy; Arina J. ten CateHoek | Zendy

Open Access

Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

Author(s) -

Anouk J. W. Gulpen,

Dionne C.W. Braeken,

Simon Schalla,

Hugo Ten Cate,

Harry J. Crijns,

Arina J. ten CateHoek

Publication year - 2022

Publication title -

acta haematologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.574

H-Index - 56

eISSN - 1421-9662

pISSN - 0001-5792

DOI - 10.1159/000524094

Subject(s) - medicine , atrial fibrillation , medication adherence , stroke (engine) , mechanical engineering , engineering

Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research